Unit of Geriatric Pharmacoepidemiology, Research Hospital of Cosenza, Italian National Research Centre on Aging (INRCA), Cosenza, Italy.
Drugs Aging. 2009 Dec;26 Suppl 1:31-9. doi: 10.2165/11534640-000000000-00000.
Balanced and safe prescribing is difficult to achieve in frail older adults with multiple comorbid diseases. This issue is of particular concern, especially in elderly hospitalized patients because hospitalization exposes such individuals to an increased risk of adverse drug reactions (ADRs). The avoidance of medications that are considered to be inappropriate is among the interventions for treatment options in elderly patients. A potentially inappropriate medication (PIM) is a drug in which the risk of an adverse event outweighs its clinical benefit, particularly when there is a safer or more effective alternative therapy for the same condition. Explicit criteria have been developed to identify PIMs and among these, Beers' criteria are the most frequently applied in the literature. However, evidence suggests that such criteria cannot easily be applied to elderly hospitalized people in European countries; approximately 20% of drugs listed in Beers' criteria are rarely prescribed or are not available in Europe, and Beers' listed PIMs are not associated with inhospital mortality, length of hospital stay and/or ADRs in Italian studies. On the contrary, ADRs can contribute to accelerated functional decline in elderly hospitalized patients independently of the use of Beers' listed PIMs. Therefore, we will review the evidence pertaining to the application of Beers' criteria in elderly hospitalized patients, while focusing on Italian studies that have investigated the role of PIMs as potential predictors of negative hospital outcomes. In addition, we will also review the available evidence regarding new European criteria on identifying PIMs, because clinical application in elderly hospitalized Europeans is still under investigation.
在患有多种合并症的体弱老年人中,实现平衡和安全的处方开具颇具难度。这一问题尤其值得关注,尤其是在老年住院患者中,因为住院会使此类人群面临更高的药物不良反应风险。避免使用被认为不适当的药物是老年患者治疗选择的干预措施之一。潜在不适当药物(PIM)是指一种药物,其不良事件的风险超过了其临床获益,特别是当有相同病症的更安全或更有效的替代疗法时。已经制定了明确的标准来识别 PIM,其中,Beers 标准在文献中应用最广泛。然而,有证据表明,这些标准在欧洲国家的老年住院患者中不易应用;Beers 标准中列出的约 20%的药物很少开处方或在欧洲不可用,而且 Beers 列出的 PIM 与意大利研究中的住院内死亡率、住院时间和/或药物不良反应无关。相反,药物不良反应可能会导致老年住院患者的功能衰退加速,而与使用 Beers 列出的 PIM 无关。因此,我们将回顾 Beers 标准在老年住院患者中的应用证据,同时重点关注意大利的研究,这些研究调查了 PIM 作为负面医院结局的潜在预测因子的作用。此外,我们还将回顾有关识别 PIM 的新欧洲标准的现有证据,因为在欧洲老年人中的临床应用仍在研究之中。